Your browser doesn't support javascript.
loading
Safe(r) by design guidelines for the nanotechnology industry.
Sánchez Jiménez, Araceli; Puelles, Raquel; Perez-Fernandez, Marta; Barruetabeña, Leire; Jacobsen, Nicklas Raun; Suarez-Merino, Blanca; Micheletti, Christian; Manier, Nicolas; Salieri, Beatrice; Hischier, Roland; Tsekovska, Rositsa; Handzhiyski, Yordan; Bouillard, Jacques; Oudart, Yohan; Galea, Karen S; Kelly, Sean; Shandilya, Neeraj; Goede, Henk; Gomez-Cordon, Julio; Jensen, Keld Alstrup; van Tongeren, Martie; Apostolova, Margarita D; Llopis, Isabel Rodríguez.
Afiliação
  • Sánchez Jiménez A; Institute of Occupational Medicine (IOM), Research Avenue North, Edinburgh, UK. Electronic address: araceli.sanchez@insst.mites.gob.es.
  • Puelles R; Avanzare Innovación Tecnológica S.L., Av. Lentiscares, 4-6, 26370 Navarrete, La Rioja, Spain.
  • Perez-Fernandez M; Avanzare Innovación Tecnológica S.L., Av. Lentiscares, 4-6, 26370 Navarrete, La Rioja, Spain.
  • Barruetabeña L; GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Parque Tecnológico de Bizkaia, E-48170 Zamudio, Spain.
  • Jacobsen NR; National Research Centre for the Working Environment (NRCWE), Lersoe Park Alle 105, 2100 Copenhagen, Denmark.
  • Suarez-Merino B; TEMAS AG, 8048 Zurich, Switzerland.
  • Micheletti C; TEMAS AG, 8048 Zurich, Switzerland.
  • Manier N; Institut national de l'environnement industriel et des risques (INERIS), Verneuil-en-Halatte 60550, France.
  • Salieri B; TEMAS AG, 8048 Zurich, Switzerland; Swiss Federal Laboratories for Materials Science and Technology (Empa), Technology and Society Lab (TSL), Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland.
  • Hischier R; Swiss Federal Laboratories for Materials Science and Technology (Empa), Technology and Society Lab (TSL), Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland.
  • Tsekovska R; Roumen Tsanev Institute of Molecular Biology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., bl. 21, 1113 Sofia, Bulgaria.
  • Handzhiyski Y; Roumen Tsanev Institute of Molecular Biology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., bl. 21, 1113 Sofia, Bulgaria.
  • Bouillard J; Institut national de l'environnement industriel et des risques (INERIS), Verneuil-en-Halatte 60550, France.
  • Oudart Y; Nanomakers, 1 Rue de Clairefontaine, 78 120 Rambouillet, France.
  • Galea KS; Institute of Occupational Medicine (IOM), Research Avenue North, Edinburgh, UK.
  • Kelly S; Nanotechnology Industries Association (NIA), Avenue Tervueren 143, 1150 Brussels, Belgium.
  • Shandilya N; TNO, Princetonlaan 6, 3584 CB Utrecht, Netherlands.
  • Goede H; TNO, Princetonlaan 6, 3584 CB Utrecht, Netherlands.
  • Gomez-Cordon J; Avanzare Innovación Tecnológica S.L., Av. Lentiscares, 4-6, 26370 Navarrete, La Rioja, Spain.
  • Jensen KA; National Research Centre for the Working Environment (NRCWE), Lersoe Park Alle 105, 2100 Copenhagen, Denmark.
  • van Tongeren M; School of Health Sciences, The University of Manchester, Oxford Rd., Manchester M13 9PL,UK.
  • Apostolova MD; Roumen Tsanev Institute of Molecular Biology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., bl. 21, 1113 Sofia, Bulgaria.
  • Llopis IR; GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Parque Tecnológico de Bizkaia, E-48170 Zamudio, Spain.
NanoImpact ; 25: 100385, 2022 01.
Article em En | MEDLINE | ID: mdl-35559891
Expectations for safer and sustainable chemicals and products are growing to comply with the United Nations and European strategies for sustainability. The application of Safe(r) by Design (SbD) in nanotechnology implies an iterative process where functionality, human health and safety, environmental and economic impact and cost are assessed and balanced as early as possible in the innovation process and updated at each step. The EU H2020 NanoReg2 project was the first European project to implement SbD in six companies handling and/or manufacturing nanomaterials (NMs) and nano-enabled products (NEP). The results from this experience have been used to develop these guidelines on the practical application of SbD. The SbD approach foresees the identification, estimation, and reduction of human and environmental risks as early as possible in the development of a NM or NEP, and it is based on three pillars: (i) safer NMs and NEP; (ii) safer use and end of life and (iii) safer industrial production. The presented guidelines include a set of information and tools that will help deciding at each step of the innovation process whether to continue, apply SbD measures or carry out further tests to reduce uncertainty. It does not intend to be a prescriptive protocol where all suggested steps have to be followed to achieve a SbD NM/NEP or process. Rather, the guidelines are designed to identify risks at an early state and information to be considered to identify those risks. Each company adapts the approach to its specific needs and circumstances as company decisions influence the way forward.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanotecnologia / Nanoestruturas Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanotecnologia / Nanoestruturas Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article